UK optometrists given prescribing powers

Article

Optometrists in the UK will soon be given the power to prescribe drugs for conditions such as dry eye.

Optometrists in the UK will soon be given the power to prescribe drugs for conditions such as dry eye.

Some optometrists are already able to write prescriptions but they are required to have them signed off by a doctor. The new legislation will allow them to prescribe drugs for dry eye and conjunctivitis without a doctor having to be involved, once they have undergone additional training.

Chairman of the British Medical Association's ophthalmic group committee, Rhod Daniel, believes that it is a good move that will reduce non-sight threatening referrals to eye hospitals and free up general practitioners' time for more urgent matters. However, he has also warned that it must be carefully monitored to ensure patient safety takes precedence over convenience and economic concerns.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.